2010Journal of University of South ChinaRequires access

Drug Resistance of Pseudomonas Aeruginosa Strains in ICU

HU Si-hai

Open publisher page 0 citations

Abstract

Objective To investigate the clinical distribution and drug resistance of P.aeruginosa infection in the ICU of our hospital and provide basis for rational drug therapy.Methods Samples isolated from ICU between July 2008 and October 2009 were carried out routine culture and identification for pathogenic bacteria.And drug sensitivity test was performed.Clinical distribution and drug resistance of P.aeruginosa were obtained by statistical analysis.Results 101 P.aeruginosa strains were derived from clinical specimens,and most isolated from sputum samples accounting for 65(64. 3%).Drug resistant rate of P.aeruginosa to ampicillin was the highest(98%),to meropenem was lower(33.7%),to polymyxin E was the lowest(8.9%).And resistance to other antimicrobial agents varied.Conclusions The rate of P. aeruginosa infection in ICU is highly prominent,and its drug resistance and multiple drug resistance are serious.Antimicrobial treatment to P.aeruginosa infection should be guided by drug sensitivity test.

About this research paper

What this paper is about

Objective To investigate the clinical distribution and drug resistance of P.aeruginosa infection in the ICU of our hospital and provide basis for rational drug therapy.Methods Samples isolated from ICU between July 2008 and October 2009 were carried out routine culture and identification for pathogenic bacteria.And drug sensitivity test was performed.Clinical distribution and drug resistance of P.aeruginosa were obtained by statistical analysis.Results 101 P.aeruginosa strains were derived from clinical specimens,and most isolated from sputum samples accounting for 65(64. 3%).Drug resistant rate of P.aeruginosa to ampicillin was the highest(98%),to meropenem was lower(33.7%),to polymyxin E was the lowest(8.9%).And resistance to other antimicrobial agents varied.Conclusions The rate of P. aeruginosa infection in ICU is highly prominent,and its drug resistance and multiple drug resistance are serious.Antimicrobial treatment to P.aeruginosa infection should be guided by drug sensitivity test.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical distribution and drug resistance of P.aeruginosa infection in the ICU of our hospital and provide basis for rational drug therapy.Methods Samples isolated from ICU between July 2008 and October 2009 were carried out routine culture and identification for pathogenic bacteria.And drug sensitivity test was performed.Clinical distribution and drug resistance of P.aeruginosa were obtained by statistical analysis.Results 101 P.aeruginosa strains were derived from clinical specimens,and most isolated from sputum samples accounting for 65(64. 3%).Drug resistant rate of P.aeruginosa to ampicillin was the highest(98%),to meropenem was lower(33.7%),to polymyxin E was the lowest(8.9%).And resistance to other antimicrobial agents varied.Conclusions The rate of P. aeruginosa infection in ICU is highly prominent,and its drug resistance and multiple drug resistance are serious.Antimicrobial treatment to P.aeruginosa infection should be guided by drug sensitivity test.

Key concepts: Pseudomonas aeruginosa, Drug resistance, Polymyxin, Antimicrobial, Microbiology, Medicine, Meropenem, Sputum

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug Resistance of Pseudomonas Aeruginosa Strains in ICU — Research Paper | ScholarLens